Liver Cancer
Copyright ©The Author(s) 2004.
World J Gastroenterol. Mar 15, 2004; 10(6): 813-818
Published online Mar 15, 2004. doi: 10.3748/wjg.v10.i6.813
Table 1 Concentration of VEGF in supernatant of Walker-256 cells (pg/ml)(mean ± SD)
Group0.25 μmol/L0.5 μmol/L1.0 μmol/L2.0 μmol/L
Antisense ODNs84.2 ± 2.279.2 ± 2.674.4 ± 2.165.2 ± 2.0
Sense ODNs89.2 ± 1.990.4 ± 2.688.2 ± 1.988.6 ± 2.5
Control90.2 ± 1.990.8 ± 1.889.4 ± 2.190.4 ± 1.7
F values7.87723.13249.906133.636
P values0.02110.00210.00010.0001
Table 2 Inhibitory effect of supernatants of Walker-256 cells cultured with ODNs on ECV-304 proliferation (OD) (mean ± SD)
Group0.25 μmol/L0.5 μmol/L1.0 μmol/L2.0 μmol/L
Antisense ODNs0.339 ± 0.0120.332 ± 0.0060.327 ± 0.0080.321 ± 0.019
Sense ODNs0.345 ± 0.0210.348 ± 0.0140.336 ± 0.0220.359 ± 0.014
Control0.357 ± 0.0100.359 ± 0.0080.356 ± 0.0050.360 ± 0.009
F values2.4775.57312.9317.296
P values0.1640.04310.00710.0251
Table 3 Volumes and growth rates of transplanted liver tu-mors (mean ± SD)
GroupVolume of pre-TAE(mm3)Volume of post-TAE(mm3)Growth rate (%)
Control212.3 ± 117.5823.3 ± 426.1403.9 ± 69.4
LP174.6 ± 106.5286.0 ± 186.4177.9 ± 64.9
LP+ODNs173.9 ± 91.8337.6 ± 98.1140.1 ± 33.8
F values0.43214.31960.019
P values0.6530.00010.000
Table 4 Expression of VEGF and MVD by immunohistochemi-cal staining (n=10)
GroupMVD (mean ± SD)VEGF
++++++-Positive rate (%)
Control73.2 ± 20.4322370
LP80.3 ± 18.5342190
LP+ODNs53.1 ± 18.4122550
Test valuesF = 5.440H = 3.731
P values0.01010.1545